AAO calls for elimination of step therapy protocols during pandemic

Step therapy protocols and prior authorization regulations in Medicare Advantage and Part D plans are limiting access to needed medications and should be suspended by CMS for the duration of the COVID-19 pandemic, according to the clinical spokesperson for the American Academy of Ophthalmology
“The Academy has requested there be an immediate suspension of all step therapy requirements by Medicare Advantage plans and, in fact, by all commercial carriers as well,” George A. Williams, MD, told Healio/OSN.
A CMS spokesperson told Healio/OSN the organization officially suggested Medicare

Full Story →